Serum N-Glycan alteration associated with renal cell carcinoma detected by high throughput Glycan analysis

Journal of Urology

Volumn 191, Issue 3, 2014, Pages 805-813

  Hatakeyama, Shingo ^a   Amano, Maho ^b   Tobisawa, Yuki ^a   Yoneyama, Tohru ^a   Tsuchiya, Norihiko ^c   Habuchi, Tomonori ^c   Nishimura, Shin Ichiro ^b   Ohyama, Chikara ^a  

^a HIROSAKI UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c AKITA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

biological markers; carcinoma; diagnosis; kidney; lipid linked oligosaccharides; renal cell

Indexed keywords

BIOLOGICAL MARKERS; CARCINOMA; DIAGNOSIS; KIDNEY; LIPID-LINKED OLIGOSACCHARIDES; RENAL CELL;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; CASE-CONTROL STUDIES; HUMANS; KIDNEY NEOPLASMS; MIDDLE AGED; POLYSACCHARIDES; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84893858712     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.10.052     Document Type: Article

References (26)

1. A. Stenzl, and J.B. deKernion The natural history of renal cell carcinoma Semin Urol 7 1989 144
2. S. Naito, N. Yamamoto, and T. Takayama et al. Prognosis of Japanese metastatic renal cell carcinoma patients in the cytokine era: a cooperative group report of 1463 patients Eur Urol 57 2009 317
3. K. Saito, and K. Kihara Role of C-reactive protein as a biomarker for renal cell carcinoma Expert Rev Anticancer Ther 10 2010 1979
4. J.Y. Blay, S. Negrier, and V. Combaret et al. Serum level of interleukin 6 as a prognosis factor in metastatic renal cell carcinoma Cancer Res 52 1992 3317
5. M.K. Kashyap, A. Kumar, and N. Emelianenko et al. Biochemical and molecular markers in renal cell carcinoma: an update and future prospects Biomarkers 10 2005 258
6. H. Ishimura, T. Takahashi, and H. Nakagawa et al. N- acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer Clin Cancer Res 12 2006 2506
7. S. Hagisawa, C. Ohyama, and T. Takahashi et al. Expression of core 2 beta1,6-N-acetylglucosaminyltransferase facilitates prostate cancer progression Glycobiology 15 2005 1016
8. S. Hatakeyama, A. Kyan, and H. Yamamoto et al. Core 2 N-acetylglucosaminyltransferase-1 expression induces aggressive potential of testicular germ cell tumor Int J Cancer 127 2010 1052
9. S. Saito, S. Orikasa, and C. Ohyama et al. Changes in glycolipids in human renal-cell carcinoma and their clinical significance Int J Cancer 49 1991 329
10. S. Nishimura, K. Niikura, and M. Kurogochi et al. High-throughput protein glycomics: combined use of chemoselective glycoblotting and MALDI-TOF/TOF mass spectrometry Angew Chem Int Ed Engl 44 2004 91
11. Y. Miura, Y. Shinohara, and J. Furukawa et al. Rapid and simple solid-phase esterification of sialic acid residues for quantitative glycomics by mass spectrometry Chemistry 13 2007 4797
12. K. Nouso, M. Amano, and Y.M. Ito et al. Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer J Gastroenterol 48 2013 1171
13. R.J. Motzer, M. Mazumdar, and J. Bacik et al. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma J Clin Oncol 17 1999 2530
14. L.H. Sobin, M.K. Gospodarowicz, and C. Wittekind et al. TNM Classification of Malignant Tumours, 7th ed 2009 Wiley-Blackwell Hoboken 310
15. International Agency for Research on Cancer: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Edited by J Eble, J Epstein, I Sesterhenn et al. Lyon: IARC Press 2004; p 359.
16. B. Ljungberg, D.C. Hanbury, and M.A. Kuczyk et al. Renal cell carcinoma guideline Eur Urol 51 2007 1502
17. A.K. Akobeng Understanding diagnostic tests 3: receiver operating characteristic curves Acta Paediatr 96 2007 644
18. S. Nishimura Toward automated glycan analysis Adv Carbohydr Chem Biochem 65 2011 219
19. S. Hakomori Tumor-associated carbohydrate antigens defining tumor malignancy: basis for development of anti-cancer vaccines Adv Exp Med Biol 491 2001 369
20. W.R. Alley Jr., M. Madera, and Y. Mechref et al. Chip-based reversed-phase liquid chromatography-mass spectrometry of permethylated N-linked glycans: a potential methodology for cancer-biomarker discovery Anal Chem 82 2010 5095
21. J. Bones, J.C. Byrne, and N. O'Donoghue et al. Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms J Proteome Res 10 2011 1246
22. A. D'Arrigo, C. Belluco, and A. Ambrosi et al. Metastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma Int J Cancer 115 2005 256
23. N. Okuyama, Y. Ide, and M. Nakano et al. Fucosylated haptoglobin is a novel marker for pancreatic cancer: a detailed analysis of the oligosaccharide structure and a possible mechanism for fucosylation Int J Cancer 118 2006 2803
24. T. Nakagawa, E. Miyoshi, and T. Yakushijin et al. Glycomic analysis of alpha-fetoprotein L3 in hepatoma cell lines and hepatocellular carcinoma patients J Proteome Res 7 2008 2222
25. K. Moriwaki, K. Noda, and T. Nakagawa et al. A high expression of GDP-fucose transporter in hepatocellular carcinoma is a key factor for increases in fucosylation Glycobiology 17 2007 1311
26. S.K. Pal, M. Kortylewski, and H. Yu et al. Breaking through a plateau in renal cell carcinoma therapeutics: development and incorporation of biomarkers Mol Cancer Ther 9 2010 3115